Related Companies

[]

Related Funds

[]

Turkish

English

oda_NewBusinessRelationAbstract|

New Business Relation

oda_UpdateAnnouncementFlag|

Update Notification Flag

Hayır (No)

oda_CorrectionAnnouncementFlag|

Correction Notification Flag

Hayır (No)

oda_DateOfThePreviousNotificationAboutTheSameSubject|

Date Of The Previous Notification About The Same Subject

oda_DelayedAnnouncementFlag|

Postponed Notification Flag

Hayır (No)

oda_AnnouncementContentSection|

Announcement Content

oda_NatureOfTheOtherPartyWithWhichNewBusinessRelationWillStart|

Nature Of The Other Party With Which New Business Relation Will Start

Tedarikçi (Supplier)

oda_NameSurnameOrCompanyTitleOfCustomerOrSupplier|

Name Surname Or Company Title Of Customer Or Supplier

Moderna Switzerland GMBH

oda_IfExistsShareOfCustomerOrSupplierInNetSalesOrCostOfGoodsSoldOnLatestDisclosedProfitOrLossAndOtherComprehensiveIncomeStatementOfCompany|

If Exists Share Of Customer Or Supplier In Net Sales Or Cost Of Goods Sold On Latest Disclosed Profit Or Loss And Other Comprehensive Income Statement Of Company

oda_IfExistsShareOfCustomerOrSupplierInTradeReceivablesOrDebtsOnLatestDisclosedStatementofFinancialPositionOfCompany|

If Exists Share Of Customer Or Supplier In Trade Receivables Or Debts On Latest Disclosed Statement of Financial Position Of Company

oda_ExpectedStartingDateOfNewBusinessRelation|

Expected Starting Date O fNew Business Relation

oda_IfExistSignificantProvisionsOfTheContractTextBlock|

If Exist Significant Provisions Of The Contract

Aşağıda Belirtilmiştir.

Detailed Below.

oda_ImpactOfNewBusinessRelationOnCompanyActivities|

Impact Of New Business Relation On Company Activities

Olumlu olması beklenmektedir.

Positive Impact is Expected

oda_ExplanationSection|

Explanations

oda_ExplanationTextBlock|

GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. ("GEN"), Aeschenvorstadt 48, 4051 Basel, İsviçre'de yerleşik MODERNA SWITZERLAND GMBH ("MODERNA") ile, MODERNA tarafından geliştirilen, SARS-CoV-2 virüsünün ön füzyonla stabilize edilmiş spike (S) proteininin tamamını kodlayan benzersiz bir lipid nanoparçacık (LNP) içine kapsüllenmiş mRNA temelli aşı olan mRNA-1273 ürünü için, ("Aşı") 13 Mayıs 2022 tarihinde "YEREL TEMSİLCİ VE HİZMET ANLAŞMASI" imzalamıştır.

YEREL TEMSİLCİ VE HİZMET ANLAŞMASI gereğince GEN, MODERNA'nın Türkiye'de münhasır hizmet sağlayıcısı ve temsilcisi olacak ve MODERNA'ya Aşının Türkiye'de olası tedariki için iş olanakları sağlamak konusunda yardım edecektir.

İşbu açıklamamızın İngilizce çevirisi ekte yer almakta olup, metinler arasında herhangi bir farklılık olması durumunda, Türkçe açıklama metni esas kabul edilecektir.

-Unofficial Translation-

GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. ("GEN") has signed with MODERNA SWITZERLAND GMBH, located at Aeschenvorstadt 48, 4051 Basel, Switzerland ("MODERNA") LOCAL REPRESENTATIVE AND SERVICES AGREEMENT on 13 May 2022, with regard to the product developed by MODERNA, mRNA-1273, which is a novel lipid nanoparticle (LNP) encapsulated mRNA-based vaccine that encodes for a full-length, prefusion stabilized spike (S) protein of SARS-CoV-2 ("the Vaccine").

Under the LOCAL REPRESENTATIVE AND SERVICES AGREEMENT, GEN will act as MODERNA's exclusive local service provider and representative in Turkey to assist MODERNA in facilitating business with respect to the possible supply of the Vaccine in Turkey.